Related Experiment Video

Updated: Oct 3, 2025

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.6K

Fixing the GAP: The role of RhoGAPs in cancer

Gabriel Kreider-Letterman1, Nicole M Carr1, Rafael Garcia-Mata1

  • 1Department of Biological Sciences, The University of Toledo, Toledo OH, USA.

European Journal of Cell Biology
|February 18, 2022
PubMed

Insights

Rho GTPase-activating proteins (RhoGAPs) are crucial regulators of cancer progression. This review highlights their role in cancer development and therapeutic potential.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Cancer progression and metastasis involve significant cellular changes, including alterations in Rho GTPase signaling.
  • Rho GTPases are key signaling proteins regulating fundamental cellular processes, and their dysregulation is common in cancer.
  • Rho GTPase signaling is modulated by guanine nucleotide-exchange factors (RhoGEFs) and GTPase activating proteins (RhoGAPs).

Purpose of the Study:

  • To review recent advances in understanding the role of RhoGAPs in cancer.
  • To discuss the significance of RhoGAPs in cancer development and progression.
  • To explore the therapeutic potential of targeting RhoGAPs in cancer treatment.

Main Methods:

  • Literature review of studies on RhoGAPs and cancer.
  • Analysis of the regulatory mechanisms of RhoGAPs in cellular signaling.
  • Synthesis of current knowledge on RhoGAP involvement in cancer progression and metastasis.

Main Results:

  • RhoGAP family members are increasingly recognized as critical regulators of cancer development.
  • Aberrant RhoGAP activity contributes to uncontrolled cell growth, invasion, and metastasis.
  • Targeting RhoGAPs presents a promising avenue for novel cancer therapeutics.

Conclusions:

  • RhoGAPs play a pivotal role in cancer pathogenesis by modulating Rho GTPase activity.
  • Understanding RhoGAP function is essential for developing effective anti-cancer strategies.
  • Further research into RhoGAP-targeted therapies holds significant promise for oncology.
Keywords:
CancerCell adhesion, cell migrationCell invasionCytsokeletonMetastasisOncogeneRho GTPasesRhoGAPsTumor suppressor

More Related Videos

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

548
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.4K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K